SARAH HUBBARD: Open Payments
NPI 1891871836 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,128 in 25 payments from 7 companies in 2025. Trend: 2023 $8,134 · 2024 $9,659 · 2025 $8,128
Speaker / faculty: $4,885Travel & lodging: $2,179Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 17 | $7,612 |
| Tarsus Pharmaceuticals, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Astellas Pharma US Inc | 3 | $78 |
| Ipsen Biopharmaceuticals, Inc | 1 | $44 |
| GlaxoSmithKline, LLC. | 1 | $27 |
Products named: Epclusa, XDEMVY, Wegovy, Veozah, IQIRVO.
Industry payments across VA — which companies pay providers there.
